SLNO Annual Total Long Term Liabilities
$11.68 M
+$2.84 M+32.18%
31 December 2023
Summary:
As of January 23, 2025, SLNO annual total long term liabilities is $11.68 million, with the most recent change of +$2.84 million (+32.18%) on December 31, 2023. During the last 3 years, it has risen by +$862.00 thousand (+7.97%). SLNO annual total long term liabilities is now -53.79% below its all-time high of $25.27 million, reached on December 31, 2013.SLNO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLNO Quarterly Long Term Liabilities
$17.05 M
+$2.82 M+19.83%
30 September 2024
Summary:
As of January 23, 2025, SLNO quarterly total long term liabilities is $17.05 million, with the most recent change of +$2.82 million (+19.83%) on September 30, 2024. Over the past year, it has increased by +$5.71 million (+50.37%). SLNO quarterly long term liabilities is now -59.87% below its all-time high of $42.48 million, reached on September 30, 2014.SLNO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLNO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.2% | +50.4% |
| 3 y3 years | +8.0% | +50.4% |
| 5 y5 years | +7.5% | +50.4% |
SLNO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.2% | at high | +94.3% |
| 5 y | 5-year | -36.0% | +32.2% | -6.7% | +94.3% |
| alltime | all time | -53.8% | +2665.6% | -59.9% | +3936.2% |
Soleno Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.05 M(+19.8%) |
| June 2024 | - | $14.22 M(+18.7%) |
| Mar 2024 | - | $11.99 M(+2.6%) |
| Dec 2023 | $11.68 M(+32.2%) | $11.68 M(+3.0%) |
| Sept 2023 | - | $11.34 M(+16.6%) |
| June 2023 | - | $9.72 M(+6.4%) |
| Mar 2023 | - | $9.13 M(+3.4%) |
| Dec 2022 | $8.84 M(-9.4%) | $8.84 M(-6.4%) |
| Sept 2022 | - | $9.44 M(+1.4%) |
| June 2022 | - | $9.31 M(+6.1%) |
| Mar 2022 | - | $8.77 M(-10.1%) |
| Dec 2021 | $9.75 M(-9.8%) | $9.75 M(-26.8%) |
| Sept 2021 | - | $13.32 M(+2.6%) |
| June 2021 | - | $12.98 M(+34.8%) |
| Mar 2021 | - | $9.63 M(-11.0%) |
| Dec 2020 | $10.82 M(-40.8%) | $10.82 M(-31.5%) |
| Sept 2020 | - | $15.78 M(+10.2%) |
| June 2020 | - | $14.32 M(-6.7%) |
| Mar 2020 | - | $15.35 M(-16.0%) |
| Dec 2019 | $18.26 M | $18.26 M(+75.8%) |
| Sept 2019 | - | $10.39 M(-40.4%) |
| June 2019 | - | $17.44 M(+34.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $12.99 M(+19.6%) |
| Dec 2018 | $10.86 M(+3.7%) | $10.86 M(-23.1%) |
| Sept 2018 | - | $14.12 M(-9.3%) |
| June 2018 | - | $15.56 M(+36.9%) |
| Mar 2018 | - | $11.37 M(+8.6%) |
| Dec 2017 | $10.47 M(+2379.8%) | $10.47 M(+626.7%) |
| Sept 2017 | - | $1.44 M(-8.3%) |
| June 2017 | - | $1.57 M(+1.4%) |
| Mar 2017 | - | $1.55 M(+266.8%) |
| Dec 2016 | $422.30 K(-76.3%) | $422.30 K(-48.5%) |
| Sept 2016 | - | $820.00 K(-19.9%) |
| June 2016 | - | $1.02 M(+4.8%) |
| Mar 2016 | - | $977.00 K(-45.3%) |
| Dec 2015 | $1.78 M(-90.2%) | $1.78 M(-30.0%) |
| Sept 2015 | - | $2.55 M(-16.4%) |
| June 2015 | - | $3.05 M(-85.0%) |
| Mar 2015 | - | $20.31 M(+11.0%) |
| Dec 2014 | $18.30 M(-27.6%) | $18.30 M(-56.9%) |
| Sept 2014 | - | $42.48 M(+2.9%) |
| June 2014 | - | $41.30 M(+65.0%) |
| Mar 2014 | - | $25.03 M(-1.0%) |
| Dec 2013 | $25.27 M(+0.4%) | $25.27 M |
| Dec 2012 | $25.17 M | - |
FAQ
- What is Soleno Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Soleno Therapeutics?
- What is Soleno Therapeutics annual total long term liabilities year-on-year change?
- What is Soleno Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly long term liabilities year-on-year change?
What is Soleno Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SLNO is $11.68 M
What is the all time high annual total long term liabilities for Soleno Therapeutics?
Soleno Therapeutics all-time high annual total long term liabilities is $25.27 M
What is Soleno Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SLNO annual total long term liabilities has changed by +$2.84 M (+32.18%)
What is Soleno Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SLNO is $17.05 M
What is the all time high quarterly long term liabilities for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly total long term liabilities is $42.48 M
What is Soleno Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SLNO quarterly total long term liabilities has changed by +$5.71 M (+50.37%)